CHEST 2020

Conference Coverage

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

Publish Date May 9, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

ACE-Induced Angioedema Prevalence in African Americans

By

Brandon May

Publish Date November 11, 2020

The prevalence of angioedema induced by ACE inhibitors was found to be higher in African Americans compared with other races.

Mechanically Ventilated Patients With COPD May Benefit From Early Tracheostomy

By

Britt Gambino

Publish Date November 3, 2020

Researchers conducted a retrospective analysis of patients with COPD who were hospitalized and mechanically ventilated.

Revefenacin Plus Formoterol Via Nebulization Improves Lung Function Response in COPD

By

Brandon May

Publish Date November 3, 2020

Once-daily revefenacin when administered via a jet nebulizer with formoterol was well tolerated and associated with greater lung function response compared with formoterol alone in patients with COPD.

Inhaled Corticosteroid Therapy May Reduce Lung Function Decline in COPD

By

Madeline Morr

Publish Date November 3, 2020

The adjusted rate of decline in predose trough FEV1 during 52 weeks in theResearchers used a substudy of the Phase 3 ETHOS study to evaluate lung function decline in patients with inhaled corticosteroid-containing therapies vs glycopyrrolate/formoterol fumarate metered dose inhaler.

Switch to Extra-Fine Inhaled Triple Therapy Improves Regional Ventilation to Small Airways in COPD

By

Brandon May

Publish Date November 3, 2020

Switching from non-extra fine multi-inhaler triple therapy to single-inhaler extra-fine inhaled triple therapy improved regional ventilation to the small airways in patients with COPD.

Acute COPD Exacerbations May Be Linked to Higher HbA1c Levels

By

Madeline Morr

Publish Date November 3, 2020

Patients with chronic obstructive pulmonary disease (COPD) who have higher levels of HbA1c are at increased risk for hospital admission for acute exacerbations.

Cardiovascular Adverse Event Risk Following a COPD Exacerbation

By

Britt Gambino

Publish Date November 3, 2020

In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.

Pulmonary Hypertension May Increase In-Hospital Mortality in Acute COPD Exacerbations

By

Brandon May

Publish Date October 21, 2020

Pulmonary hypertension is associated with higher in-hospital mortality, morbidity, length of stay, and health care utilization in patients admitted to the hospital with an acute exacerbation of COPD.

Increased GERD Risk in End-Stage Lung Disease Without Esophageal Disease

By

Meghna Rao

Publish Date October 21, 2020

End-stage lung disease may significantly increase the risk for gastroesophageal reflux disease (GERD) in patients undergoing lung transplant without primary esophageal disease.